Cancer vaccines: comprehensive review.

BJS Open · 2026 · PMC13220758 · PMID 42213481

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

narrowly missed statistical significanceno p-value reported

The phase III trial demonstrated a trend in favour of adding the vaccine (median PFS 19.4 versus 11 months), although this narrowly missed statistical significance.

also in 227 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.